Lancet:December 19, 2025: Persistence to antihypertensive drug classes in uncomplicated hypertension: a nationwide Swedish cohort study

This nationwide Swedish study investigates how the choice of an initial blood pressure medication influences whether a patient will remain on their treatment over several years. By analyzing data from hundreds of thousands of individuals, researchers discovered that those starting with angiotensin receptor blockers (ARBs) demonstrated the highest level of long-term consistency and the fewest changes in therapy. While previous assumptions suggested that only half of patients stick to their prescriptions, this research reveals a more optimistic reality where eighty percent of users continue their regimen over a five-year period. Ultimately, the study suggests that the initial drug class plays a pivotal role in maintaining health habits, effectively challenging old myths about patient non-compliance in hypertension management.